CSIMarket
 


Maravai Lifesciences Holdings Inc   (MRVI)
Other Ticker:  
 

Maravai Lifesciences Holdings Inc 's Leverage Ratio

MRVI's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 0.25%, Leverage Ratio fell to 1.96, below the Maravai Lifesciences Holdings Inc 's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 358 other companies have achieved lower Leverage Ratio than Maravai Lifesciences Holdings Inc in the III Quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the second quarter 2023 from 1718 to 2593 .

Explain Leverage Ratio?
Who are MRVI Customers?
What are MRVI´s Total Liabilities?


MRVI Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change 6.01 % 16.01 % 37.65 % 65.99 % 85.55 %
Y / Y Total Liabilities Change 0.51 % 1.99 % 8.26 % 8.88 % 14.03 %
Leverage Ratio MRQ 1.96 1.94 1.99 1.92 2.07
MRVI's Total Ranking # 2593 # 1718 # 2560 # 1278 # 2740
Seq. Equity Change -0.6 % -0.33 % -0.51 % 7.55 % 8.77 %
Seq. Total Liabilities Change 0.25 % -2.79 % 3.45 % -0.31 % 1.73 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 359
Healthcare Sector # 737
Overall Market # 2593


Leverage Ratio Statistics
High Average Low
5.34 2.74 1.92
(Mar 31 2021)   (Dec 31 2022)




Financial Statements
Maravai Lifesciences Holdings Inc 's Equity $ 892 Millions Visit MRVI's Balance sheet
Maravai Lifesciences Holdings Inc 's Total Liabilities $ 1,748 Millions Visit MRVI's Balance sheet
Source of MRVI's Sales Visit MRVI's Sales by Geography


Cumulative Maravai Lifesciences Holdings Inc 's Leverage Ratio

MRVI's Leverage Ratio for the trailling 12 Months

MRVI Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth 6.01 % 16.01 % 37.65 % 65.99 % 85.55 %
Y / Y Total Liabilities TTM Growth 0.51 % 1.99 % 8.26 % 8.88 % 14.03 %
Leverage Ratio TTM 1.95 1.98 2.04 2.15 2.38
Total Ranking TTM # 12 # 10 # 1270 # 12 # 1846
Seq. Equity TTM Growth -0.6 % -0.33 % -0.51 % 7.55 % 8.77 %
Seq. Total Liabilities TTM Growth 0.25 % -2.79 % 3.45 % -0.31 % 1.73 %


On the trailing twelve months basis Despite of the net new borrowings of 0.25% during the twelve months period ending in III Quarter 2023 Maravai Lifesciences Holdings Inc has managed to decrease Leverage Ratio in the III Quarter 2023 to 1.95, below Maravai Lifesciences Holdings Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry MRVI recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 10 to 12.

Explain Leverage Ratio?
Who are MRVI Customers?
What are MRVI´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 1
Within the Market # 12


trailing twelve months Leverage Ratio Statistics
High Average Low
3.39 2.12 1.54
(Dec 31 2021)   (Sep 30 2023)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
Arcutis Biotherapeutics Inc   5.27 $ 246.242  Millions$ 46.717  Millions
Clearmind Medicine Inc   5.05 $ 4.970  Millions$ 0.983  Millions
Innovation Pharmaceuticals Inc   4.74 $ 5.505  Millions$ 1.162  Millions
Amicus Therapeutics inc   4.73 $ 630.847  Millions$ 133.237  Millions
Unicycive Therapeutics Inc   4.72 $ 16.008  Millions$ 3.390  Millions
Teva Pharmaceutical Industries Limited  4.68 $ 35,158.000  Millions$ 7,512.000  Millions
Petros Pharmaceuticals inc   4.61 $ 31.982  Millions$ 6.933  Millions
Intercept Pharmaceuticals inc   4.47 $ 321.317  Millions$ 71.845  Millions
Blueprint Medicines Corporation  4.46 $ 902.688  Millions$ 202.611  Millions
Kala Bio inc   4.45 $ 49.897  Millions$ 11.223  Millions
Puma Biotechnology Inc   4.26 $ 164.863  Millions$ 38.742  Millions
Celularity Inc   4.20 $ 126.945  Millions$ 30.247  Millions
Mustang Bio inc   4.13 $ 16.558  Millions$ 4.009  Millions
Mersana Therapeutics Inc   4.04 $ 210.709  Millions$ 52.195  Millions
Vbi Vaccines Inc  3.88 $ 77.194  Millions$ 19.886  Millions
Biolinerx Ltd   3.83 $ 50.702  Millions$ 13.223  Millions
Aytu Biopharma Inc   3.13 $ 100.721  Millions$ 32.167  Millions
Sarepta Therapeutics Inc   3.04 $ 2,322.856  Millions$ 764.357  Millions
Eli Lilly And Company  2.94 $ 33,266.700  Millions$ 11,307.400  Millions
Harrow Inc   2.79 $ 210.308  Millions$ 75.402  Millions
Kineta Inc   2.77 $ 7.991  Millions$ 2.889  Millions
Marinus Pharmaceuticals Inc   2.65 $ 144.368  Millions$ 54.537  Millions
Journey Medical Corporation  2.62 $ 45.447  Millions$ 17.374  Millions
Durect Corp  2.55 $ 36.752  Millions$ 14.406  Millions
Apellis Pharmaceuticals Inc   2.52 $ 585.945  Millions$ 232.271  Millions
Proqr Therapeutics N v   2.33 $ 108.072  Millions$ 46.357  Millions
Gossamer Bio Inc   2.33 $ 243.308  Millions$ 104.617  Millions
Phibro Animal Health Corporation  2.27 $ 620.465  Millions$ 273.069  Millions
Uniqure N v   2.21 $ 594.878  Millions$ 268.784  Millions
Biovie Inc   2.15 $ 16.212  Millions$ 7.548  Millions

Date modified: 2023-11-09T19:11:56+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com